News

Filter

Briefs: Merz Pharma pulls out of Obagi bid; Aubagio approved in Argentina

08-04-2013

German family-owned Merz Pharma says that it has withdrawn its non-binding proposal to acquire all of…

AubagioBiotechnologyGenzymeMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalRegulationSanofiSouth AmericaValeant Pharmaceuticals

Valeant on acquisition trail again

12-03-2012

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

Valeant bags another company, Eyetech

14-02-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has agreed…

BiotechnologyEyetechMacugenMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Valeant to acquire Australia’s iNova for up to $946 million

22-11-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) has signed…

BiotechnologyiNovaMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Cephalon accepts Teva’s $6.8 billion takeover, again snubbing Valiant’s $5.7 billion bid

03-05-2011

US biotechnology firm Cephalon (Nasdaq: CEPH) has agreed to accept Israel generics giant Teva Pharmaceutical…

BiotechnologyCephalonMergers & AcquisitionsPharmaceuticalTeva Pharmaceutical IndustriesValeant Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top